FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3040956314> ?p ?o ?g. }

• W3040956314 endingPage "348" @default.
• W3040956314 startingPage "348" @default.
• W3040956314 abstract "Background and objectives: Everolimus (EVE) is a mammalian target of the rapamycin (mTOR) inhibitor that is widely used in cancer patients. Pulmonary toxicity, usually manifesting as interstitial pneumonitis, is a serious adverse effect of this drug. Radiation therapy, which is often administered in conjunction with chemotherapy for synergistic effects, also causes pulmonary fibrosis. In view of pulmonary damage development in these two forms of cancer treatment, we have examined the effect of EVE administration individually, in combination with radiation given in varying sequences, and its relation to the extent of pulmonary damage. Materials and Methods: We performed an experimental study in albino rats, which were randomized into five groups: (1) control group, (2) EVE alone, (3) EVE 22 h after radiation, (4) EVE 2 h after irradiation, and (5) only radiation. Sixteen weeks after thoracic irradiation, rat lung tissue samples were examined under light microscopy, and the extent of pulmonary damage was estimated. After this, we calculated median fibrosis scores in each group. Results: The highest fibrosis score was noted in Group 4. Among the five groups, the control group had a significantly lower median fibrosis score compared to the others. When the median fibrosis score of the group that received concurrent EVE with radiation therapy (RT) (Group 4) was compared with that of the control group, the difference was statistically significant (p = 0.0022). However, no significant differences were achieved among the study groups that received EVE only or RT only, whether concurrently or sequentially (p > 0.05). Conclusion: EVE is an effective treatment option for the management of several malignancies and is often combined with other therapies, such as radiation, for a more efficient response. However, an increased risk of pulmonary fibrosis should also be anticipated when these two modalities are combined, as they both can cause pulmonary damage, especially when administered concurrently." @default.
• W3040956314 created "2020-07-16" @default.
• W3040956314 creator A5007217329 @default.
• W3040956314 creator A5012650103 @default.
• W3040956314 creator A5016203021 @default.
• W3040956314 creator A5018221400 @default.
• W3040956314 creator A5020904045 @default.
• W3040956314 creator A5021589412 @default.
• W3040956314 creator A5032410695 @default.
• W3040956314 creator A5045144310 @default.
• W3040956314 creator A5047842820 @default.
• W3040956314 creator A5051449965 @default.
• W3040956314 creator A5066600370 @default.
• W3040956314 date "2020-07-13" @default.
• W3040956314 modified "2023-10-01" @default.
• W3040956314 title "The Impact of Everolimus and Radiation Therapy on Pulmonary Fibrosis" @default.
• W3040956314 cites W1953808663 @default.
• W3040956314 cites W1986665437 @default.
• W3040956314 cites W1998682495 @default.
• W3040956314 cites W2001518113 @default.
• W3040956314 cites W2004520476 @default.
• W3040956314 cites W2039202337 @default.
• W3040956314 cites W2063987453 @default.
• W3040956314 cites W2077429419 @default.
• W3040956314 cites W2100336633 @default.
• W3040956314 cites W2111076375 @default.
• W3040956314 cites W2122674755 @default.
• W3040956314 cites W2138129102 @default.
• W3040956314 cites W2143842256 @default.
• W3040956314 cites W2144810965 @default.
• W3040956314 cites W2148993732 @default.
• W3040956314 cites W2151082560 @default.
• W3040956314 cites W2167188058 @default.
• W3040956314 cites W2316942600 @default.
• W3040956314 cites W2330622603 @default.
• W3040956314 cites W2338868660 @default.
• W3040956314 cites W2896878953 @default.
• W3040956314 cites W2969658762 @default.
• W3040956314 cites W636925189 @default.
• W3040956314 doi "https://doi.org/10.3390/medicina56070348" @default.
• W3040956314 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7404687" @default.
• W3040956314 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32668776" @default.
• W3040956314 hasPublicationYear "2020" @default.
• W3040956314 type Work @default.
• W3040956314 sameAs 3040956314 @default.
• W3040956314 citedByCount "2" @default.
• W3040956314 countsByYear W30409563142021 @default.
• W3040956314 countsByYear W30409563142022 @default.
• W3040956314 crossrefType "journal-article" @default.
• W3040956314 hasAuthorship W3040956314A5007217329 @default.
• W3040956314 hasAuthorship W3040956314A5012650103 @default.
• W3040956314 hasAuthorship W3040956314A5016203021 @default.
• W3040956314 hasAuthorship W3040956314A5018221400 @default.
• W3040956314 hasAuthorship W3040956314A5020904045 @default.
• W3040956314 hasAuthorship W3040956314A5021589412 @default.
• W3040956314 hasAuthorship W3040956314A5032410695 @default.
• W3040956314 hasAuthorship W3040956314A5045144310 @default.
• W3040956314 hasAuthorship W3040956314A5047842820 @default.
• W3040956314 hasAuthorship W3040956314A5051449965 @default.
• W3040956314 hasAuthorship W3040956314A5066600370 @default.
• W3040956314 hasBestOaLocation W30409563141 @default.
• W3040956314 hasConcept C126322002 @default.
• W3040956314 hasConcept C126894567 @default.
• W3040956314 hasConcept C197934379 @default.
• W3040956314 hasConcept C2776256026 @default.
• W3040956314 hasConcept C2777714996 @default.
• W3040956314 hasConcept C2779524853 @default.
• W3040956314 hasConcept C2779699572 @default.
• W3040956314 hasConcept C2780559512 @default.
• W3040956314 hasConcept C2781047374 @default.
• W3040956314 hasConcept C2781244666 @default.
• W3040956314 hasConcept C509974204 @default.
• W3040956314 hasConcept C71924100 @default.
• W3040956314 hasConcept C90924648 @default.
• W3040956314 hasConceptScore W3040956314C126322002 @default.
• W3040956314 hasConceptScore W3040956314C126894567 @default.
• W3040956314 hasConceptScore W3040956314C197934379 @default.
• W3040956314 hasConceptScore W3040956314C2776256026 @default.
• W3040956314 hasConceptScore W3040956314C2777714996 @default.
• W3040956314 hasConceptScore W3040956314C2779524853 @default.
• W3040956314 hasConceptScore W3040956314C2779699572 @default.
• W3040956314 hasConceptScore W3040956314C2780559512 @default.
• W3040956314 hasConceptScore W3040956314C2781047374 @default.
• W3040956314 hasConceptScore W3040956314C2781244666 @default.
• W3040956314 hasConceptScore W3040956314C509974204 @default.
• W3040956314 hasConceptScore W3040956314C71924100 @default.
• W3040956314 hasConceptScore W3040956314C90924648 @default.
• W3040956314 hasIssue "7" @default.
• W3040956314 hasLocation W30409563141 @default.
• W3040956314 hasLocation W30409563142 @default.
• W3040956314 hasOpenAccess W3040956314 @default.
• W3040956314 hasPrimaryLocation W30409563141 @default.
• W3040956314 hasRelatedWork W114545845 @default.
• W3040956314 hasRelatedWork W1480041025 @default.
• W3040956314 hasRelatedWork W1588066003 @default.
• W3040956314 hasRelatedWork W1964464065 @default.
• W3040956314 hasRelatedWork W1994362420 @default.
• W3040956314 hasRelatedWork W2011862468 @default.

• next